Showing results (61-70 of 209) with videos related to
Sort By:
Pageof 21
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2016
Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis ImagingNeeta Pandit-Taskar, Darren R Veach, Josef J Fox, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2023
Radioimmunoscintigraphy and Pretreatment Dosimetry of 131I-Omburtamab for Planning Treatment of Leptomeningeal DiseaseNeeta Pandit-Taskar, Milan Grkovski, Pat B Zanzonico, et al.Pediatric Blood & Cancer|January 17, 2016
Feasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined RoomsBae P Chu, Christopher Horan, Ellen Basu, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Positron Lymphography via Intracervical 18F-FDG Injection for Presurgical Lymphatic Mapping in Cervical and Endometrial MalignanciesJennifer J Mueller, Lawrence T Dauer, Rajmohan Murali, et al.Clinical Imaging|August 21, 2021
FDG PET/CT imaging features and clinical utility in COVID-19Randy Yeh, Ahmed Elsakka, Rick Wray, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2021
Biodistribution and Radiation Dosimetry of Intraperitoneally Administered 124I-Omburtamab in Patients with Desmoplastic Small Round Cell TumorsMilan Grkovski, Shakeel Modak, Pat B Zanzonico, et al.AJR. American Journal of Roentgenology|July 8, 2016
Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin MicrospheresWaleed Shady, Vlasios S Sotirchos, Richard K Do, et al.Pediatric Blood & Cancer|November 2, 2007
Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapyShakeel Modak, Neeta Pandit-Taskar, Brian H Kushner, et al.Urologia|May 16, 2024
Does enzalutamide related PSMA upregulation affect outcomes of lutetium-177 PSMA radioligand therapy?Turgut Bora Cengiz, Raksha Kulkarni, Matteo Novello, et al.Research Square|March 11, 2024
Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal diseaseKavya Prasad, Brian E Serencsits, Bae P Chu, et al.Pageof 21